相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Redox Regulation of Multidrug Resistance in Cancer Chemotherapy: Molecular Mechanisms and Therapeutic Opportunities
Macus Tien Kuo
ANTIOXIDANTS & REDOX SIGNALING (2009)
Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances
K. -John J. Cheung et al.
BLOOD (2009)
Expression of MRP1, BCRP, LRP and ERCC1 in Advanced Non-Small-Cell Lung Cancer: Correlation With Response to Chemotherapy and Survival
Jian Li et al.
CLINICAL LUNG CANCER (2009)
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
Roland Schmitz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
B and T Lymphocyte Attenuator Regulates B Cell Receptor Signaling by Targeting Syk and BLNK
Andrew C. Vendel et al.
JOURNAL OF IMMUNOLOGY (2009)
Overexpressed NF-κB-inducing kinase contributes to the tumorigenesis of adult T-cell leukemia and Hodgkin Reed-Sternberg cells
Yasunori Saitoh et al.
BLOOD (2008)
Topoisomerase IIα expression as an independent prognostic factor in Hodgkin's lymphoma
Ipatia A. Doussis-Anagnostopoulou et al.
CLINICAL CANCER RESEARCH (2008)
Gene expression profiles of Hodgkin's lymphoma cell lines with different sensitivity to cytotoxic drugs
Martin S. Staege et al.
EXPERIMENTAL HEMATOLOGY (2008)
Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization
Sylvia Hartmann et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis
Verena Brune et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Genetic changes in the evolution of multidrug resistance for cultured human ovarian cancer cells
Timon P. H. Buys et al.
GENES CHROMOSOMES & CANCER (2007)
Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis
Charles W. Ross et al.
CLINICAL CANCER RESEARCH (2007)
HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma
Arjan Diepstra et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A detailed inventory of DNA copy number alterations in four commonly used Hodgkin's lymphoma cell lines
Tom Feys et al.
HAEMATOLOGICA (2007)
Resolving the resolution of array CGH
Bradley P. Coe et al.
GENOMICS (2007)
Aberrant NF-kappa B signaling in lymphoma: mechanisms, consequences, and therapeutic implications
Philipp J. Jost et al.
BLOOD (2007)
Imbalances of chromosome arm 1p in pediatric and adult germ cell tumors are caused by true allelic loss:: A combined comparative genomic hybridization and microsatellite analysis
Susanne Zahn et al.
GENES CHROMOSOMES & CANCER (2006)
Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma
Abel Sanchez-Aguilera et al.
BLOOD (2006)
Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma
Jose I. Martin-Subero et al.
BLOOD (2006)
Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma
M Haber et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A multiplex PCR predictor for aCGH success of FFPE samples
EH van Beers et al.
BRITISH JOURNAL OF CANCER (2006)
Expression of bcl-2 in classical Hodgkin's lymphoma: An independent predictor of poor outcome
SJ Sup et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
High-resolution array CGH increases heterogeneity tolerance in the analysis of clinical samples
C Garnis et al.
GENOMICS (2005)
Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: The Austrian breast and colorectal cancer study group
M Filipits et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells
T Alvaro et al.
CLINICAL CANCER RESEARCH (2005)
A tiling resolution DNA microarray with complete coverage of the human genome
AS Ishkanian et al.
NATURE GENETICS (2004)
Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes
JP Gillet et al.
CANCER RESEARCH (2004)
Cytogenetic and comparative genomic hybridization findings in four cases of breast cancer after neoadjuvant chemotherapy
B Fazeny-Dörner et al.
CANCER GENETICS AND CYTOGENETICS (2003)
Classical Hodgkin lymphoma is associated with frequent gains of 17q
DTY Chui et al.
GENES CHROMOSOMES & CANCER (2003)
Long-term cause-specific mortality of patients treated for Hodgkin's disease
BMP Aleman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease
V Diehl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma
TFE Barth et al.
BLOOD (2003)
Transcriptional analysis of the B cell germinal center reaction
U Klein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: Report of an intergroup trial
DB Duggan et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2
S Joos et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease:: a randomised trial
N Schmitz et al.
LANCET (2002)
Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2
S Joos et al.
BLOOD (2002)
Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma
JI Martín-Subero et al.
BLOOD (2002)